Matthew G. Kaag, M.D.

Urology Urologic Oncology

Bladder Cancer Kidney cancer Prostate cancer Testicular Cancer Penile Cancer Genitourinary Sarcoma Show all patient services »

Fellowship, Urologic Oncology, Memorial Sloan Kettering Cancer Center (New York) (2010) Residency, Urology, Milton S. Hershey Medical Center (2007) Internship, Surgery, General, Milton S. Hershey Medical Center (2003) M.D., Penn State Hershey College of Medicine (2002)

Non-Operative Treatment of Bladder Cancer Chemoprevention of Urologic Cancers Operative Management of Bladder and Upper Tract Urothelial Cancers

Shikanov S, Clark MA, Raman JD, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS Jr, Huang WC, Shalhav AL, Eggener SE
Chronic kidney disease epidemiology collaboration versus modification of diet in renal disease equations for renal function evaluation in patients undergoing partial nephrectomy.
J Urol. September 2010, Epub ahead of print. Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, Bochner BH, Coleman J, Dalbagni G
Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?
Eur. Urol. August 2010, Epub ahead of print. Kaag M, O’Malley R, O’Malley P, Godoy G, Chen M, Smaldone M, Hrebinko R, Raman J, Bochner B, Dalbagni G, Stifelman M, Taneja S, Huang W
Changes in renal function following nephroureterectomy may impact the use of perioperative chemotherapy.
Eur. Urol.  2010; 58(4): 581-7. Kaag M, Toyen C, Cronin A, Thompson R, Bernstein M, Russo P, Bains M
Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU International.
September 2010, Epub ahead of print. Kaag M, Dalbagni G, Herr H, Bajorin D, Milowsky M, Bochner BH
The risk of regional lymph node involvement in radical cystectomy patients without residual invasive disease following chemotherapy.
BJU International, accepted for publication, October, 2010.